[The motility-inhibiting effect of adrenergic beta receptor stimulating agents in dependence on the duration of pregnancy].
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005865:Gestational Age; D007545:Isoproterenol / Q000494:pharmacology; D007743:Labor, Obstetric / Q000187:drug effects; D008722:Methods; D009119:Muscle Contraction / Q000187:drug effects; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D009756:Nylidrin / Q000494:pharmacology; D011247:Pregnancy; D051381:Rats; D013997:Time Factors; D014599:Uterus / Q000187:drug effects*
D000318:Adrenergic beta-Agonists; D009125:Muscle Relaxants, Central; D009756:Nylidrin; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine
Die motilitätshemmende Wirksamkeit von Substanzen mit stimulierender Wirkung auf die adrenergen beta-Rezeptoren in Abhägigkeit von der Trachtigkeitsdauer.